Celcuity Inc. (CELC) Stock Ticker
CELC right now
Market factors today
Unlock the full CELC picture
About Celcuity Inc.
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
CELC stock facts
| Ticker symbol | CELC |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $3.9B |
| CEO | Brian F. Sullivan |
| Employees | 155 |
| Headquarters | Minneapolis, MN, US |
| IPO date | 2017-09-19 |
| Website | www.celcuity.com |
What you can see for CELC on Tickr
Live CELC price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the CELC report.
Rankings
FAQ
What is the ticker symbol for Celcuity Inc.?
The ticker symbol for Celcuity Inc. is CELC, listed on the NASDAQ.
What is CELC?
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular…